Trials / Completed
CompletedNCT02868060
Evaluating the Pharmacokinetics and Pharmacodynamics of Romiplostim in Patients With Immune Thrombocytopenia (ITP)
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Kyowa Kirin China Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The objective of evaluating the pharmacokinetics and pharmacodynamics of romiplostim in patients with immune thrombocytopenia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Romiplostim |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2017-08-01
- Completion
- 2017-08-01
- First posted
- 2016-08-16
- Last updated
- 2024-04-29
Locations
5 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02868060. Inclusion in this directory is not an endorsement.